Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
J.B.CHEMICALS & PHARMACEUTICALS LTD.
JBCHEPHARM | BSE
1,454.75
INR-43.65
-2.91%
JBCHEPHARM | BSE
About J.B.CHEMICALS & PHARMACEUTICALS LTD.
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/09/2023
As of date
08/12/2023
Close
1,454.75
Open
1,515.00
High
1,516.50
Low
1,439.95
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations herbal remedies and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine Ranitidine and Metronidazole. The company also provides contract manufacturing services for tablets lozenges injectables gels creams ointments liquid herbal syrups and capsules; and soft-centered powder medicated and herbal lozenges as well as various pharmaceutical dosage forms. In addition it offers a range of contrast media products including x-ray magnetic resonance imaging (MRI) and ultrasound scanners. Further the company provides its services in gastroenterology hypertension diabetes dermatology nephrology wound care anti-infectives and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai India.
View LessJBCHEPHARM | BSE
Risk
28.4%
Sharpe
-0.56
Luna's Score
46/100
Recommendation
Hold
Luna says (JBCHEPHARM | BSE)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Weakness based on declining price with high volume
High 6-Month Volatility (>65%)
Midcap (2B - 10B USD)
Weak P/E, and PEG ratio indicator
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
30.6%1 month
28.4%3 months
108.1%6 months
81.1%Return
Fundamental Ratios
PE
47.17
Fwd. PE
32.47
Price to book
8.29
Debt to equity
0.17
Debt to assets
0.12
Ent. to EBITDA
27.02
Ent. to rev.
6.77
PEG
0
Other Fundamentals
EBITDA
8.15B
MarketCap
225.74B
MarketCap(USD)
2.71B
Div. yield
0.64
Op. margin
23.97
Erngs. growth
33.80
Rev. growth
8.90
Ret. on equity
19.34
Short ratio
0
Short perc.
0
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
177.85
Range1M
177.85
Range3M
1.80K
Volumes: Market Activity
Rel. volume
1.82
Price X volume
17.54M
